Leaflet CLORURA DE POTASIU KABI 150mg / ml concentrate for solution for infusion


Indicated for: mineral deficiency; mineral supplementation

Route of administration: infusion

Substance: potassium chloride (mineral)

ATC: B05XA01 (Blood and blood forming organs | I.v. solution additives | Electrolyte solutions)

Potassium chloride is used for the treatment and prevention of hypokalemia, a condition characterized by low potassium levels in the blood. It helps maintain normal muscle, nerve, and heart function.

The medication is administered orally or intravenously, as directed by a doctor. It is important to monitor blood potassium levels to avoid hyperkalemia.

Side effects may include nausea, vomiting, abdominal discomfort, or injection site irritation. In rare cases, hyperkalemia or cardiac arrhythmias may occur.

Potassium chloride is not recommended for patients with hyperkalemia, severe renal impairment, or hypersensitivity to this medication.

General data about CLORURA DE POTASIU KABI 150mg / ml

  • Substance: potassium chloride
  • Date of last drug list: 01-05-2026
  • Commercial code: W56126003
  • Concentration: 150mg / ml
  • Pharmaceutical form: concentrate for solution for infusion
  • Quantity: 20
  • Product type: generic
  • Price: 41.20 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: FRESENIUS KABI ESPANA, S.A. - SPANIA
  • Holder: FRESENIUS KABI ROMANIA S.R.L. - ROMANIA
  • Number: 5479/2013/03
  • Shelf life: 2 years-after packing for marketing;after the first opening-it is used immediately

Concentrations available for potassium chloride

  • 149mg/ml
  • 150mg/ml
  • 7.45%
  • 74.56mg/ml